See how your answers relate to your colleagues'.

Findings from a 3-month, multicenter, retrospective study on Type 2 Diabetes treatment with a tubeless insulin pump, showed:
a. Significant increase in mean HbA1c.
b. No significant change at 3 months from pre-patch pump treatment.
c. A slight reduction in mean HbA1c.
d. A significant reduction in mean HbA1c level of -1.2% (1.4) from baseline on MDI therapy.

Submit is supported by independent educational grants from Insulet Corporation, Madrigal Pharmaceuticals, MannKind Corporation, Medtronic, Stanford University, and Tandem Diabetes Care, Inc.
©2024 CogniMed Inc. All rights reserved.